Opioid Use Disorder Treatment Linkage at Strategic Touchpoints Using Buprenorphine (OUTLAST-B): Rationale, Design, and Evolution of a Randomized Controlled Trial is a research paper published in Journal of Psychiatry and Brain Science (2023). On theSindex it has a DataRank of 0.106. It has been cited 1 time, with 1 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
2.03 × 10⁻³
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 1 citer.
NIDA NIH HHS
Grant: R01 DA045724
NIDA NIH HHS
Grant: T32 DA007209
National Institutes of Health
Grant: 5T32DA007209-30
Human Behavioral Pharmacology of Substance Abuse
National Institutes of Health
Grant: 5R01DA045724-02
Opioid Use Disorder Treatment Linkage at STD Clinics using Buprenorphine (OUTLAST-B)
FWCI
0.24
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals